{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T00:01:53Z","timestamp":1792281713181,"version":"4.4.0"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.neures.2026.105138","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:12:29Z","timestamp":1791645149000},"page":"105138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Models with human relevance and patient specificity in neurodegenerative diseases"],"prefix":"10.1016","volume":"232","author":[{"given":"Haruhisa","family":"Inoue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neures.2026.105138_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.neures.2025.104985","article-title":"Drug discovery research with iPSC models of neurodegenerative diseases","volume":"222","author":"Adachi","year":"2026","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neures.2026.105138_bib2","author":"FDA (U.S. Food and Drug Administration)","year":"2025","journal-title":"Roadmap to Reducing Animal Testing in Preclinical Safety Studies"},{"key":"10.1016\/j.neures.2026.105138_bib3","unstructured":"FDA (U.S. Food and Drug Administration), 2025b. FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs [News release, 10 April 2025]. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-announces-plan-phase-out-animal-testing-requirement-monoclonal-antibodies-and-other-drugs (accessed 30 September 2026)."},{"key":"10.1016\/j.neures.2026.105138_bib4","article-title":"General Considerations for the Use of New Approach Methodologies in Drug Development","author":"FDA (U.S. Food and Drug Administration)","year":"2026","journal-title":"Draft Guidance for Industry (Docket No. FDA-2025-D-6131)"},{"key":"10.1016\/j.neures.2026.105138_bib5","author":"FDA (U.S. Food and Drug Administration)","year":"2026","journal-title":"Reducing Animal Testing in Nonclinical Studies: Year One Progress and the Path Forward"},{"key":"10.1016\/j.neures.2026.105138_bib6","unstructured":"FDA (U.S. Food and Drug Administration), 2026c. FDA Updates Regulations to Advance Innovative Alternatives to Animal Testing [News release, 21 September 2026]. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-updates-regulations-advance-innovative-alternatives-animal-testing (accessed 30 September 2026)."},{"key":"10.1016\/j.neures.2026.105138_bib7","unstructured":"NIH (National Institutes of Health), 2025a. NIH to Prioritize Human-Based Research Technologies [News release, 29 April 2025]. https:\/\/www.nih.gov\/news-events\/news-releases\/nih-prioritize-human-based-research-technologies (accessed 30 September 2026)."},{"key":"10.1016\/j.neures.2026.105138_bib8","unstructured":"NIH (National Institutes of Health), 2025b. NIH Funding Announcements to Align with NIH Initiative to Prioritize Human-based Research [NIH Extramural Nexus, 10 July 2025]. https:\/\/grants.nih.gov\/news-events\/nih-extramural-nexus-news\/2025\/07\/nih-funding-announcements-to-align-with-nih-initiative-to-prioritize-human-based-research (accessed 30 September 2026)."},{"key":"10.1016\/j.neures.2026.105138_bib9","unstructured":"NIH (National Institutes of Health), 2026. NIH Launches New Office to Advance Human-Based Research and Reduce Animal Use [News release, 15 June 2026]. https:\/\/www.nih.gov\/news-events\/news-releases\/nih-launches-new-office-advance-human-based-research-reduce-animal-use (accessed 30 September 2026)."},{"key":"10.1016\/j.neures.2026.105138_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.neures.2025.104991","article-title":"Neurodegenerative disease and autophagy in iPSC-based models","volume":"222","author":"Odonchimed","year":"2026","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neures.2026.105138_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.neures.2025.104980","article-title":"iPSC-derived neural organoids in dementia research: recent advances and future directions","volume":"221","author":"Shima","year":"2025","journal-title":"Neurosci. Res."}],"container-title":["Neuroscience Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168010226001252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168010226001252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:28:10Z","timestamp":1791977290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168010226001252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":11,"alternative-id":["S0168010226001252"],"URL":"https:\/\/doi.org\/10.1016\/j.neures.2026.105138","relation":{},"ISSN":["0168-0102"],"issn-type":[{"value":"0168-0102","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Models with human relevance and patient specificity in neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neures.2026.105138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105138"}}